European stocks rise for a second straight day on Wednesday, but with drugmakers capping gains after a late-session selloff following remarks by U.S. President-elect Donald Trump.
Latest posts by Market Watch (see all)
- Metals Stocks: Gold set for fresh 3-month high as dollar slides - February 24, 2017
- Futures Movers: Oil prices step back, with U.S. rig count data ahead - February 24, 2017
- Europe Markets: European stocks under pressure as BASF, RBS drop - February 24, 2017